Press Releases
June 9, 2023
April 4, 2023
IgGenix Announces Patent Granted by USPTO Covering the Generation of Allergen-Specific Antibodies
March 2, 2023
February 6, 2023
August 19, 2022
How Re-Engineering Antibodies Can Prevent Allergies (Labiotech.eu)
July 1, 2022
IgGenix Demonstrates Potential for Single-Cell RNA-Sequencing in Tree Nut Allergies
April 26, 2022
IgGenix Announces Move of Headquarters to Lilly Gateway Labs in South San Francisco
February 23, 2022
July 27, 2021
June 24, 2021
IgGenix Announces Jessica Grossman, M.D., as Chief Executive Officer